Suppr超能文献

[严重肺栓塞纤溶过程中的血流动力学变化]

[Hemodynamic course during fibrinolysis in severe pulmonary embolism].

作者信息

Ohayon J, Colle J P, Tauzin-Fin P, Lorient-Roudaut M F, Besse P

出版信息

Arch Mal Coeur Vaiss. 1986 Apr;79(4):445-53.

PMID:3090962
Abstract

Seventy seven cases of severe pulmonary embolism (Miller index greater than 13 points) including 61 acute (under 5 days) and 16 subacute episodes, underwent continuous haemodynamic monitoring during treatment with either urokinase 2 000 U/kg/h for 24 hours with heparin (Group I: 18 patients), or urokinase 4 500 U/kg/h for 12 hours without heparin (Group II: 47 patients), or with streptokinase 2 00 000 U over 10 hours (Group III: 12 patients). Efficacy was defined as greater than 20% improvement of Miller index at control angiography after 48 hours (Group I: 10 patients, Group II: 31 patients, Group III: 8 patients). In the 49 patients (63%) with good results, the Miller index fell by about 50% with a significant increase in cardiac index (20%) from the 12th hour. There was a concomitant fall in pulmonary systolic arterial pressure (35%). In the 28 patients (37%) with partial improvement a 20% increase in cardiac index and an 18% fall in pulmonary systolic arterial pressure were observed only in the high dose urokinase group, despite incomplete pulmonary revascularisation demonstrating the vasodilator effect of this protocol. Fibrinolysis was repeated in the patients with incomplete results or a Miller index of over 13 points, leading to improvement in 78% of patients. Accelerated lysis of pulmonary embolism leads to rapid normalisation of haemodynamic parameters and improves the prognosis of massive pulmonary embolism by reducing the number of recurrences and the mortality rate (4%).

摘要

77例严重肺栓塞患者(米勒指数大于13分),其中包括61例急性发作(病程小于5天)和16例亚急性发作,在接受治疗期间进行了连续血流动力学监测。治疗方案如下:第一组18例患者,使用尿激酶2000 U/kg/h,持续24小时,并联合肝素治疗;第二组47例患者,使用尿激酶4500 U/kg/h,持续12小时,不联合肝素治疗;第三组12例患者,使用链激酶200000 U,持续10小时。疗效定义为48小时后对照血管造影时米勒指数改善超过20%(第一组10例患者,第二组31例患者,第三组8例患者)。在49例(63%)治疗效果良好的患者中,从第12小时起,米勒指数下降约50%,心指数显著升高(20%),同时肺收缩压下降(35%)。在28例(37%)部分改善的患者中,尽管肺血管再通不完全,但仅在高剂量尿激酶组观察到心指数升高20%,肺收缩压下降18%,这表明该方案具有血管舒张作用。对治疗效果不完全或米勒指数超过13分的患者重复进行溶栓治疗,78%的患者病情得到改善。加速溶解肺栓塞可使血流动力学参数迅速恢复正常,并通过减少复发次数和死亡率(4%)改善大面积肺栓塞的预后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验